EZH2 and Miyoshi myopathy: Interestingly, we and others have shown that BAP1-deficient MM have elevated PRC2-mediated gene repression and are vulnerable to pharmacological inhibition of EZH2, the catalytic subunit of PRC2 [20, 21].